Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 14, 2017; 23(26): 4767-4778
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4767
Table 4 Treatment response assessment based on response evaluation criteria in solid tumour 1.1 criteria evaluated by magnetic resonance and computed tomography, based on Choi criteria evaluated by computed tomography, based on perfusion and diffusion parameters evaluated by dynamic contrast enhanced-magnetic resonance imaging and diffusion weighted imaging data and based on positron emission tomography response criteria in solid tumors criteria evaluated by positron emission tomography/computed tomography
No.ΔCT largest diameterΔHUΔMR largest diameterΔWISΔWOSΔDtΔfpΔDpΔSUVmaxResponse assessment
111.6%22.7%8.4%35.4%40.0%-78.1%12.1%61.9%-177.8%PR
29.1%40.4%10.4%84.7%85.0%-32.7%27.3%78.7%PR
38.5%34.0%11.5%94.0%74.4%-64.4%28.5%50.3%38.5%PR
413.6%7.8%2.0%88.0%76.0%-16.8%32.7%36.6%PR
53.9%48.7%
66.3%18.9%
727.3%49.5%
826.7%51.6%
9
1017.9%42.6%100.0%PR
11-5.4%49.1%12.1%18.4%9.7%-20.4%-33.3%5.4%66.5%SD
1212.7%6.8%19.1%57.9%98.0%-34.2%11.7%12.0%-17.9%SD
136.7%44.4%20.0%7.9%-17.4%32.52.2%36.9%46.8%PR
148.0%44.8%7.3%67.6%110.0%-32.9%44.3%92.0%44.4%PR
15-60.0%83.3%
167.5%23.4%
1723.4%35.5%16.4%55.7%307.1%-18.0%62.6%32.2%18.8%PR
18-29.4%40.0%-9.8%34.9%58.7%-16.3%46.7%66.4%17.0%PR
195.7%44.0%7.5%67.3%-24.6%-30.5%-22.6%-90.7%32.3%PR